Compare FMC Corp (FMC) vs Lowe`s Companies Inc (LOW) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Lowe's Companies (LOW) trades at $213.81, up 2.94% on the day, with a bearish technical signal but strong analyst consensus. Recent earnings beats and a 7.51% net income margin highlight operational strength, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. The stock shows support near $205 and resistance at $215, with a consensus price target of $260.88 implying 22% upside. Dividend growth remains a key attraction, with the quarterly payout rising to $1.25.

LOW offers value with a P/E of 17.72 and bullish analyst sentiment (60.79% buy ratings), but faces risks from high debt levels and competitive pressures. The outlook hinges on execution in the professional segment and interest rate sensitivity, with near-term volatility expected around Q2 earnings.